Application 209132
- Type
- ANDA
- Sponsor
- SOMERSET
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70069-161 | Cisatracurium Besylate | Cisatracurium Besylate | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-161 | Cisatracurium Besylate | Cisatracurium Besylate | Somerset Therapeutics, LLC | ANDA | Current |
| 70069-161 | Cisatracurium Besylate | Cisatracurium Besylate | Somerset Therapeutics, LLC | ANDA | Current |